P1 and P2 Purine and Pyrimidine Receptor Ligands
- 1 January 2001
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 157 references indexed in Scilit:
- Protection by an Adenosine Analogue against Kainate-Induced Extrahippocampal NeuropathologyGeneral Pharmacology: The Vascular System, 1998
- The A3Adenosine Receptor Mediates Cell Spreading, Reorganization of Actin Cytoskeleton, and Distribution of Bcl-xL: Studies in Human Astroglioma CellsBiochemical and Biophysical Research Communications, 1997
- SCH 58261: A selective A2A adenosine receptor antagonistsDrug Development Research, 1997
- Adenosine A2A antagonists with potent anti-cataleptic activityBioorganic & Medicinal Chemistry Letters, 1997
- CARDIOPROTECTIVE EFFECTS OF ADENOSINE A1AND A2ARECEPTOR AGONISTS IN THE ISOLATED RAT HEARTPharmacological Research, 1997
- Stimulation by Alkylxanthines of Chloride Efflux in CFPAC-1 Cells Does Not Involve A1 Adenosine ReceptorsBiochemistry, 1995
- Adenosine effects upon insulin action on lipolysis and glucose transport in human adipocytesMolecular and Cellular Biochemistry, 1995
- Novel competitive antagonists for P2 purinoceptorsEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- Extracellular ATP as a possible mediator of cell-mediated cytotoxicityImmunology Today, 1990
- PD 116,948, a highly selective A1 adenosine receptor antagonistLife Sciences, 1987